Skip to main content
Pathway Medicine

Search form

GoozyGooz

Become an Author
Recommended Reading
About this Resource

You are here

Home » Pharmacology » Antibacterials » Tuberculosis Chemotherapeutics

Book navigation

  • Immunology
  • Microbiology
  • Cardiovascular Medicine
  • Respiratory Medicine
  • Renal Medicine
  • Gastrointestinal Medicine
  • Hepatology
  • Endocrinology
  • Hematology and Oncology
  • Dermatology
  • Musculoskeletal System
  • Pharmacology
    • Basic Pharamacology
    • Antibacterials
      • Bacterial Cell Wall Synthesis Inhibitors
      • Bacterial Ribosome Inhibitors
      • Bacterial Gyrase Inhibitors (Fluoroquinolones)
      • Bacterial Metabolism Inhibitors
      • Tuberculosis Chemotherapeutics
        • Isoniazid
        • Pyrazinamide
        • Ethambutol
        • Streptomycin
      • Leprosy Chemotherapeutics
    • Antivirals
    • Antifungals
    • Antiprotozoals
    • Blood Pharmacology
    • Diuretics
    • GI Pharmacology
  • Basic Concepts
  • Genetic Disorders
  • Surgery
  • Neurology

Pyrazinamide

Overview
  • Pyrazinamide is used as part of multi-therapy for Mycobacterium tuberculosis. The mechanism of action of the drug is unknown. The primary adverse effect of the drug is hepatotoxicity.
‹ Isoniazid up Ethambutol ›
Copyright 2010-2015 by Pathway Medicine
Terms of Use